Vistin Pharma ASA: Invitation to Q3 2026 conference call
Oslo, Norway, 21 October 2026
Vistin Pharma ASA (VISTN) will release its third quarter and YTD 2026 results on Thursday 29th of October 2026. Vistin Pharma will host a conference call for all shareholders and interested parties on the same day at 08:30 CET. There will be a Q&A session following the management discussion.
The third quarter conference call will be available via web and audio through the following access points:
Webcast: https://edge.media-server.com/mmc/p/23oqqa3w (https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fedge.media- server.com%2Fmmc%2Fp%2F23oqqa3w&data=05%7C02%7CAlexander.Karlsen%40vistin.com%7C 07247dff87b44ce9d8d408df02865ed6%7C2fcdf060b2c2456e8bb7944b7e40981a%7C0%7C0%7C63 9232449769954980%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDA wMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=VRQlpdd 1pChh0t8vG%2FbpXiDXDvcBZqooBtwGqkB9d%2BY%3D&reserved=0)
Telephone conference (online registration):
https://register-conf.media- server.com/register/BI30c4210d68f345c0ac1a134fe4578f1c (https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fregister- conf.media- server.com%2Fregister%2FBI30c4210d68f345c0ac1a134fe4578f1c&data=05%7C02%7CAlexan der.Karlsen%40vistin.com%7C07247dff87b44ce9d8d408df02865ed6%7C2fcdf060b2c2456e8b b7944b7e40981a%7C0%7C0%7C639232449769985742%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1h cGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D %7C0%7C%7C%7C&sdata=txnJIFwl16rRiH14dlZXa5vLglCJ%2FqpBDq8C44QIdPo%3D&reserved=0)
*****
For further information, please contact:
Alexander Karlsen CFO +47 97053621 alexander.karlsen@vistin.com
About Vistin Pharma | www.vistin.com
Vistin Pharma is a Norwegian pharmaceutical company producing Metformin Hydrochloride (API). The Metformin is also available as Direct Compressible lubricated granules. As a solely dedicated European Metformin producer, Vistin Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin Pharma is headquartered in Oslo, Norway, and has highly qualified employees and a dedicated manufacturing facility in Kragerø.